FPR2 and ischemic stroke: In this study, we demonstrated that post‐ischemic intravenous treatment with BML‐111, a LXA4 receptor agonist, resulted in a sustained reduction in infarct size and improved sensory deficits in the first week following ischemic stroke in rats.